 | • レポートコード：GIR-107A14512 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エファビレンツのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エファビレンツの種類別市場規模（単一エファビレンツ、2剤併用、3剤併用）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エファビレンツの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol-Myers Squibb、Teva、Mylan、Aurobindo Pharma、Cipla、Macleods Pharmaceuticals、Hetero、Strides Pharma、Gilead Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：単一エファビレンツ、2剤併用、3剤併用 ・用途別分析2016年-2026年：大人、子供 ・エファビレンツの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エファビレンツのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エファビレンツのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エファビレンツの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エファビレンツの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Efavirenz market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Efavirenz size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Efavirenz market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Efavirenz market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Efavirenz
Two-drug combination
Three-drug combination
Market segment by Application can be divided into
Adults
Children
The key market players for global Efavirenz market are listed below:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Efavirenz product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Efavirenz, with price, sales, revenue and global market share of Efavirenz in 2018 and 2019.
Chapter 3, the Efavirenz competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Efavirenz breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Efavirenz market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Efavirenz sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Efavirenz Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Efavirenz Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Single Efavirenz
1.2.3 Two-drug combination
1.2.4 Three-drug combination
1.3 Market Analysis by Application
1.3.1 Overview: Global Efavirenz Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Efavirenz Market Size & Forecast
1.4.1 Global Efavirenz Sales in Value (2016-2026))
1.4.2 Global Efavirenz Sales in Volume (2016-2026)
1.4.3 Global Efavirenz Price by Type (2016-2026) & (USD/Unit)
1.5 Global Efavirenz Production Capacity Analysis
1.5.1 Global Efavirenz Total Production Capacity (2016-2026)
1.5.2 Global Efavirenz Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Efavirenz Market Drivers
1.6.2 Efavirenz Market Restraints
1.6.3 Efavirenz Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Efavirenz Product and Services
2.1.4 Bristol-Myers Squibb Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Efavirenz Product and Services
2.2.4 Teva Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Efavirenz Product and Services
2.3.4 Mylan Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Efavirenz Product and Services
2.4.4 Aurobindo Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Efavirenz Product and Services
2.5.4 Cipla Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Macleods Pharmaceuticals
2.6.1 Macleods Pharmaceuticals Details
2.6.2 Macleods Pharmaceuticals Major Business
2.6.3 Macleods Pharmaceuticals Efavirenz Product and Services
2.6.4 Macleods Pharmaceuticals Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Hetero
2.7.1 Hetero Details
2.7.2 Hetero Major Business
2.7.3 Hetero Efavirenz Product and Services
2.7.4 Hetero Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Strides Pharma
2.8.1 Strides Pharma Details
2.8.2 Strides Pharma Major Business
2.8.3 Strides Pharma Efavirenz Product and Services
2.8.4 Strides Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Efavirenz Product and Services
2.9.4 Gilead Sciences Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Efavirenz Sales by Manufacturer
3.1 Global Efavirenz Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Efavirenz Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Efavirenz
3.4 Market Concentration Rate
3.4.1 Top 3 Efavirenz Manufacturer Market Share
3.4.2 Top 6 Efavirenz Manufacturer Market Share
3.5 Global Efavirenz Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Efavirenz Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Efavirenz Market Size by Region
4.1.1 Global Efavirenz Sales in Volume by Region (2016-2026)
4.1.2 Global Efavirenz Revenue by Region (2016-2026)
4.2 North America Efavirenz Revenue (2016-2026)
4.3 Europe Efavirenz Revenue (2016-2026)
4.4 Asia-Pacific Efavirenz Revenue (2016-2026)
4.5 South America Efavirenz Revenue (2016-2026)
4.6 Middle East and Africa Efavirenz Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Efavirenz Sales in Volume by Type (2016-2026)
5.2 Global Efavirenz Revenue by Type (2016-2026)
5.3 Global Efavirenz Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Efavirenz Sales in Volume by Application (2016-2026)
6.2 Global Efavirenz Revenue by Application (2016-2026)
6.3 Global Efavirenz Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Efavirenz Sales by Type (2016-2026)
7.2 North America Efavirenz Sales by Application (2016-2026)
7.3 North America Efavirenz Market Size by Country
7.3.1 North America Efavirenz Sales in Volume by Country (2016-2026)
7.3.2 North America Efavirenz Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Efavirenz Sales by Type (2016-2026)
8.2 Europe Efavirenz Sales by Application (2016-2026)
8.3 Europe Efavirenz Market Size by Country
8.3.1 Europe Efavirenz Sales in Volume by Country (2016-2026)
8.3.2 Europe Efavirenz Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Efavirenz Sales by Type (2016-2026)
9.2 Asia-Pacific Efavirenz Sales by Application (2016-2026)
9.3 Asia-Pacific Efavirenz Market Size by Region
9.3.1 Asia-Pacific Efavirenz Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Efavirenz Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Efavirenz Sales by Type (2016-2026)
10.2 South America Efavirenz Sales by Application (2016-2026)
10.3 South America Efavirenz Market Size by Country
10.3.1 South America Efavirenz Sales in Volume by Country (2016-2026)
10.3.2 South America Efavirenz Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Efavirenz Sales by Type (2016-2026)
11.2 Middle East & Africa Efavirenz Sales by Application (2016-2026)
11.3 Middle East & Africa Efavirenz Market Size by Country
11.3.1 Middle East & Africa Efavirenz Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Efavirenz Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Efavirenz Typical Distributors
12.3 Efavirenz Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Efavirenz Revenue by Type, (USD Million), 2021-2026
Table 2. Global Efavirenz Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Efavirenz Product and Services
Table 6. Bristol-Myers Squibb Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Efavirenz Product and Services
Table 10. Teva Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Efavirenz Product and Services
Table 14. Mylan Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Efavirenz Product and Services
Table 18. Aurobindo Pharma Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Efavirenz Product and Services
Table 22. Cipla Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Macleods Pharmaceuticals Major Business
Table 25. Macleods Pharmaceuticals Efavirenz Product and Services
Table 26. Macleods Pharmaceuticals Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hetero Basic Information, Manufacturing Base and Competitors
Table 28. Hetero Major Business
Table 29. Hetero Efavirenz Product and Services
Table 30. Hetero Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Strides Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Strides Pharma Major Business
Table 33. Strides Pharma Efavirenz Product and Services
Table 34. Strides Pharma Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 36. Gilead Sciences Major Business
Table 37. Gilead Sciences Efavirenz Product and Services
Table 38. Gilead Sciences Efavirenz Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Efavirenz Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Efavirenz Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Efavirenz, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Efavirenz Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Efavirenz Production Site of Key Manufacturer
Table 44. Efavirenz New Entrant and Capacity Expansion Plans
Table 45. Efavirenz Mergers & Acquisitions in the Past Five Years
Table 46. Global Efavirenz Sales by Region (2016-2021e) & (K Units)
Table 47. Global Efavirenz Sales by Region (2021-2026) & (K Units)
Table 48. Global Efavirenz Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Efavirenz Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 51. Global Efavirenz Sales by Type (2021-2026) & (K Units)
Table 52. Global Efavirenz Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Efavirenz Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Efavirenz Price by Type (2016-2021e) & (USD/Unit)
Table 55. Global Efavirenz Price by Type (2021-2026) & (USD/Unit)
Table 56. Global Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 57. Global Efavirenz Sales by Application (2021-2026) & (K Units)
Table 58. Global Efavirenz Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Efavirenz Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Efavirenz Price by Application (2016-2021e) & (USD/Unit)
Table 61. Global Efavirenz Price by Application (2021-2026) & (USD/Unit)
Table 62. North America Efavirenz Sales by Country (2016-2021e) & (K Units)
Table 63. North America Efavirenz Sales by Country (2021-2026) & (K Units)
Table 64. North America Efavirenz Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Efavirenz Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 67. North America Efavirenz Sales by Type (2021-2026) & (K Units)
Table 68. North America Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 69. North America Efavirenz Sales by Application (2021-2026) & (K Units)
Table 70. Europe Efavirenz Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Efavirenz Sales by Country (2021-2026) & (K Units)
Table 72. Europe Efavirenz Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Efavirenz Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Efavirenz Sales by Type (2021-2026) & (K Units)
Table 76. Europe Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Efavirenz Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Efavirenz Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Efavirenz Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Efavirenz Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Efavirenz Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Efavirenz Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Efavirenz Sales by Application (2021-2026) & (K Units)
Table 86. South America Efavirenz Sales by Country (2016-2021e) & (K Units)
Table 87. South America Efavirenz Sales by Country (2021-2026) & (K Units)
Table 88. South America Efavirenz Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Efavirenz Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 91. South America Efavirenz Sales by Type (2021-2026) & (K Units)
Table 92. South America Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 93. South America Efavirenz Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Efavirenz Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Efavirenz Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Efavirenz Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Efavirenz Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Efavirenz Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Efavirenz Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Efavirenz Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Efavirenz Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Efavirenz Typical Distributors
Table 105. Efavirenz Typical Customers
List of Figures
Figure 1. Efavirenz Picture
Figure 2. Global Efavirenz Sales Market Share by Type in 2020
Figure 3. Single Efavirenz
Figure 4. Two-drug combination
Figure 5. Three-drug combination
Figure 6. Global Efavirenz Sales Market Share by Application in 2020
Figure 7. Adults
Figure 8. Children
Figure 9. Global Efavirenz Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Efavirenz Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Efavirenz Sales (2016-2026) & (K Units)
Figure 12. Global Efavirenz Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Efavirenz Production Capacity (2016-2026) & (K Units)
Figure 14. Global Efavirenz Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Efavirenz Market Drivers
Figure 16. Efavirenz Market Restraints
Figure 17. Efavirenz Market Trends
Figure 18. Global Efavirenz Sales Market Share by Manufacturer in 2020
Figure 19. Global Efavirenz Revenue Market Share by Manufacturer in 2020
Figure 20. Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Efavirenz Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Efavirenz Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Efavirenz Sales Market Share by Region (2016-2026)
Figure 24. Global Efavirenz Revenue Market Share by Region (2016-2026)
Figure 25. North America Efavirenz Revenue (2016-2026) & (USD Million)
Figure 26. Europe Efavirenz Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Efavirenz Revenue (2016-2026) & (USD Million)
Figure 28. South America Efavirenz Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Efavirenz Revenue (2016-2026) & (USD Million)
Figure 30. Global Efavirenz Sales Market Share by Type (2016-2026)
Figure 31. Global Efavirenz Revenue Market Share by Type (2016-2026)
Figure 32. Global Efavirenz Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Efavirenz Sales Market Share by Application (2016-2026)
Figure 34. Global Efavirenz Revenue Market Share by Application (2016-2026)
Figure 35. Global Efavirenz Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Efavirenz Sales Market Share by Type (2016-2026)
Figure 37. North America Efavirenz Sales Market Share by Application (2016-2026)
Figure 38. North America Efavirenz Sales Market Share by Country (2016-2026)
Figure 39. North America Efavirenz Revenue Market Share by Country (2016-2026)
Figure 40. United States Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Efavirenz Sales Market Share by Type (2016-2026)
Figure 44. Europe Efavirenz Sales Market Share by Application (2016-2026)
Figure 45. Europe Efavirenz Sales Market Share by Country (2016-2026)
Figure 46. Europe Efavirenz Revenue Market Share by Country (2016-2026)
Figure 47. Germany Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Efavirenz Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Efavirenz Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Efavirenz Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Efavirenz Revenue Market Share by Region (2016-2026)
Figure 56. China Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Efavirenz Sales Market Share by Type (2016-2026)
Figure 63. South America Efavirenz Sales Market Share by Application (2016-2026)
Figure 64. South America Efavirenz Sales Market Share by Country (2016-2026)
Figure 65. South America Efavirenz Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Efavirenz Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Efavirenz Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Efavirenz Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Efavirenz Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Efavirenz Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のエファビレンツ/テノホビル/エムトリシタビン併用薬市場 2021：企業別、地域別、種類・用途別 The Efavirenz/Tenofovir/Emtricitabine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- 世界のエファビレンツ/ラミブジン/テノホビル複合薬市場 2021：企業別、地域別、種類・用途別 The Efavirenz/Lamivudine/Tenofovir Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のテノホビルジソプロキシルフマル酸塩・その併用薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir Disoproxil Fumarate and Its Combination Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のテノホビル/ラミブジン/アタザナビル/リトナビル併用薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir/Lamivudine/Atazanavir/Ritonavir Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…